Short answer
Pfizer Inc (PFE) filed its Q1 2026 10-Q quarterly report on May 5, 2026 for the quarter ended Mar 29, 2026. Quarterly revenue was $14.5B (up 5.4% year over year) with net income of $2.7B.
Q1 2026 key financials · XBRL
- Revenue
- $14.5B
- +5.4% YoY
- Net income
- $2.7B
- −9.4% YoY
- EPS (diluted)
- $0.47
- −9.6% YoY
Source: XBRL data from the Pfizer Inc (PFE) Q1 2026 10-Q on SEC EDGAR. USD.
Pfizer Inc Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- MD&A excerpt contains no quarterly revenue, profitability, segment, cash-flow, or outlook data
Risk Factors
- No risk-factors text provided; excerpt begins with 2025 Form 10-K reference and Item 2
- No newly added, materially updated, regulatory, operational, competitive, or financial risks disclosed in supplied text
- First-quarter share purchases totaled 6,633,028 shares at $27.07 average price
- Remaining repurchase authorization totaled $3,292,882,444 throughout the quarter
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Pfizer Inc quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.